FR2640507A1 - Application de benzamides substitues comme anxiolytiques et anti-psychotiques - Google Patents

Application de benzamides substitues comme anxiolytiques et anti-psychotiques Download PDF

Info

Publication number
FR2640507A1
FR2640507A1 FR8816764A FR8816764A FR2640507A1 FR 2640507 A1 FR2640507 A1 FR 2640507A1 FR 8816764 A FR8816764 A FR 8816764A FR 8816764 A FR8816764 A FR 8816764A FR 2640507 A1 FR2640507 A1 FR 2640507A1
Authority
FR
France
Prior art keywords
group
ethyl
methoxy
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8816764A
Other languages
English (en)
French (fr)
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Costall
Robert Naylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Delagrange SA
Original Assignee
Laboratoires Delagrange SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Delagrange SA filed Critical Laboratoires Delagrange SA
Priority to FR8816764A priority Critical patent/FR2640507A1/fr
Priority to DK614089A priority patent/DK614089A/da
Priority to DE8989403430T priority patent/DE68901087D1/de
Priority to EP89403430A priority patent/EP0375504B1/fr
Priority to AT89403430T priority patent/ATE73998T1/de
Priority to CA002005760A priority patent/CA2005760A1/fr
Priority to JP1330962A priority patent/JPH02212476A/ja
Priority to US07/454,015 priority patent/US5086066A/en
Publication of FR2640507A1 publication Critical patent/FR2640507A1/fr
Priority to GR920401261T priority patent/GR3004911T3/el
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR8816764A 1988-12-20 1988-12-20 Application de benzamides substitues comme anxiolytiques et anti-psychotiques Withdrawn FR2640507A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8816764A FR2640507A1 (fr) 1988-12-20 1988-12-20 Application de benzamides substitues comme anxiolytiques et anti-psychotiques
DK614089A DK614089A (da) 1988-12-20 1989-12-06 Anvendelse af substituerede benzamider til fremstilling af laegemidler med anxiolytisk og antipsykotisk virkning
DE8989403430T DE68901087D1 (de) 1988-12-20 1989-12-12 Verwendung von substituierten benzamiden als anxiolytika und antipsychotika.
EP89403430A EP0375504B1 (fr) 1988-12-20 1989-12-12 Application de benzamides substitués comme anxiolytiques et anti-psychotiques
AT89403430T ATE73998T1 (de) 1988-12-20 1989-12-12 Verwendung von substituierten benzamiden als anxiolytika und antipsychotika.
CA002005760A CA2005760A1 (fr) 1988-12-20 1989-12-18 Application de benzamides substitues comme anxiolytiques et anti-psychotiques
JP1330962A JPH02212476A (ja) 1988-12-20 1989-12-19 置換ベンズアミドを有効成分とする不安解消薬および抗精神病薬
US07/454,015 US5086066A (en) 1988-12-20 1989-12-20 Method of providing anxiolytic and antipsychotic treatment with substituted benzamides
GR920401261T GR3004911T3 (enExample) 1988-12-20 1992-06-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8816764A FR2640507A1 (fr) 1988-12-20 1988-12-20 Application de benzamides substitues comme anxiolytiques et anti-psychotiques

Publications (1)

Publication Number Publication Date
FR2640507A1 true FR2640507A1 (fr) 1990-06-22

Family

ID=9373120

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8816764A Withdrawn FR2640507A1 (fr) 1988-12-20 1988-12-20 Application de benzamides substitues comme anxiolytiques et anti-psychotiques

Country Status (9)

Country Link
US (1) US5086066A (enExample)
EP (1) EP0375504B1 (enExample)
JP (1) JPH02212476A (enExample)
AT (1) ATE73998T1 (enExample)
CA (1) CA2005760A1 (enExample)
DE (1) DE68901087D1 (enExample)
DK (1) DK614089A (enExample)
FR (1) FR2640507A1 (enExample)
GR (1) GR3004911T3 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236646A1 (fr) * 1985-12-19 1987-09-16 Laboratoires DELAGRANGE, Société Anonyme Nouveaux ortho-anisamides, leur procédé d'obtention et leurs applications thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
AU534451B2 (en) * 1979-02-16 1984-02-02 Sandoz Ltd. Organic compounds and method of treatment
US4329354A (en) * 1979-06-01 1982-05-11 Sandoz Ltd. Thiazoline and imidazoline derivatives useful as antidepressants
DE3782651T2 (de) * 1987-06-17 1993-03-25 Delagrange Lab Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236646A1 (fr) * 1985-12-19 1987-09-16 Laboratoires DELAGRANGE, Société Anonyme Nouveaux ortho-anisamides, leur procédé d'obtention et leurs applications thérapeutiques

Also Published As

Publication number Publication date
DK614089D0 (da) 1989-12-06
JPH02212476A (ja) 1990-08-23
CA2005760A1 (fr) 1990-06-20
ATE73998T1 (de) 1992-04-15
EP0375504A1 (fr) 1990-06-27
DK614089A (da) 1990-06-21
EP0375504B1 (fr) 1992-03-25
DE68901087D1 (de) 1992-04-30
GR3004911T3 (enExample) 1993-04-28
US5086066A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
Posner Sedatives and tranquilizers
BG64972B1 (bg) Средство с антидепресивно действие
HU219404B (hu) Eljárás kardiális és vaszkuláris hipertrófia és/vagy hiperplazia kezelésére alkalmas angiotenzin-II-receptor blokkoló hatású vegyületet tartalmazó gyógyszerkészítmények előállítására
JPH07223951A (ja) 内寄生性生物防除剤である組成物
AU2019253831A1 (en) Compositions and methods for treating neurodegenerative diseases
US10058538B2 (en) Compositions comprising substituted benzofuroquinolizine and α2-adrenergic agonists
Asin et al. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats
EP0403360B1 (fr) Utilisation de phényléthanolamines pour la préparation de médicaments pour les affections oculaires
EP3998109A1 (en) Novel therapeutic agent for prototheca disease
EP0375504B1 (fr) Application de benzamides substitués comme anxiolytiques et anti-psychotiques
US20180221435A1 (en) Itch treatment using a combination of neurokinin-1, gastrin releasing peptide, and glutamate receptor antagonists
EP0630369B1 (en) Benzimidazole anthelmintic agents
US5538990A (en) Benzimidazole anthelmintics
US20240024299A1 (en) Use of drugs that stiffen mature gametocytes for blocking transmission of plasmodium parasites
EP0295350B1 (fr) Application du N-[2-(diethylamino)ethyl]2-methoxy 4-[(1-H 4,5-dihydro-2-imidazolyl) amino]5-chloro benzamide comme anxiolytique et anti-psychotique
JP2002544224A (ja) 環状デプシペプチド及びピペラジンを含有する殺内部寄生虫相乗性組み合わせ
US3993759A (en) Anthelmintic
EP0694303A1 (fr) Utilisation de l'eliprodil et de ses énantiomères pour la préparation de médicaments utiles dans la prévention des neuropathies induites par des agents anticancéreux, e.g. le paclitaxel
JPH07196487A (ja) 開鎖テトラデプシペプチドに基づく殺内部寄生虫性組成物
FR2641971A1 (fr) Composition pharmaceutique antihypertensive associant le benazepril et un diuretique thiazidique
AU2024271976A1 (en) Method for administering modulator targeting s1pr1 and s1pr4
US6348488B1 (en) Remedies for motor dysfunction and GAPDH expression inhibitors
US20040248926A1 (en) Preventive or remedy for pruritus
FR2640509A1 (fr) Application de la carpipramine pour obtenir un medicament destine au traitement de l'anxiete et des troubles du sommeil
HK40067673B (en) Novel therapeutic agent for prototheca disease

Legal Events

Date Code Title Description
ST Notification of lapse